Clinical and Molecular Studies of the Effect of Imatinib on Advanced Aggressive Fibromatosis (desmoid tumor)

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

2001 • 5,189 citations

Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors

2002 • 4,254 citations

Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor

2003 • 2,216 citations

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

2004 • 1,629 citations

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

2001 • 1,267 citations

Response to Imatinib Mesylate in Patients with Chronic Myeloproliferative Diseases with Rearrangements of the Platelet-Derived Growth Factor Receptor Beta

2002 • 642 citations

Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria

1992 • 619 citations

KIT-Negative Gastrointestinal Stromal Tumors

2004 • 478 citations

Molecular and Clinical Analysis of Locally Advanced Dermatofibrosarcoma Protuberans Treated With Imatinib: Imatinib Target Exploration Consortium Study B2225

2005 • 460 citations

Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs)

2004 • 331 citations

Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors).

1997 • 320 citations

Immunohistochemical Staining for KIT (CD117) in Soft Tissue Sarcomas Is Very Limited in Distribution

2002 • 317 citations

β-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds

2002 • 304 citations

Prevalence of KIT Expression in Human Tumors

2004 • 224 citations

Response of extraabdominal desmoid tumors to therapy with imatinib mesylate

2002 • 193 citations

Gastrointestinal Stromal Tumor Versus Intra-abdominal Fibromatosis of the Bowel Wall

2000 • 188 citations

Surgical management of intra-abdominal desmoid tumours

2000 • 174 citations

Desmoid fibromatosis is a clonal process

1996 • 161 citations

Radiation therapy in the management of desmoid tumors

1998 • 155 citations

Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis.

1998 • 145 citations

Aggressive Fibromatosis (Desmoid Tumor) is A Monoclonal Disorder

1997 • 138 citations

Adenomatous Polyposis Coli Gene Mutation Alters Proliferation through its β-Catenin-Regulatory Function in Aggressive Fibromatosis (Desmoid Tumor)

1998 • 130 citations

c-Kit Expression in Desmoid Fibromatosis

2003 • 110 citations

Extraabdominal desmoid tumor. A study of 83 cases.

2000 • 108 citations

Extraabdominal Desmoid Tumor

2000 • 93 citations

Desmoid tumour in familial adenomatous polyposis. A review of literature.

2001 • 71 citations

Chemotherapy for desmoid tumors in association with familial adenomatous polyposis

1997 • 68 citations

Serum KIT and KIT ligand levels in patients with gastrointestinal stromal tumors treated with imatinib

2004 • 59 citations

Desmoid tumors

2000 • 38 citations

Characterization of molecular abnormalities in human fibroblastic neoplasms: a model for genotype-phenotype association in soft tissue tumors.

2001 • 37 citations

Infliximab: A phase II trial of the tumour necrosis factor (TNFα) monoclonal antibody in patients with advanced renal cell cancer (RCC)

2004 • 8 citations